Last reviewed · How we verify
D326 and D337
D326 and D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 1 development. Also known as: CKD-386 Reference2.
At a glance
| Generic name | D326 and D337 |
|---|---|
| Also known as | CKD-386 Reference2 |
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg (PHASE1)
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg (PHASE1)
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 (PHASE3)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 (PHASE1)
- Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- D326 and D337 CI brief — competitive landscape report
- D326 and D337 updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI
Frequently asked questions about D326 and D337
What is D326 and D337?
D326 and D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.
Who makes D326 and D337?
D326 and D337 is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).
Is D326 and D337 also known as anything else?
D326 and D337 is also known as CKD-386 Reference2.
What development phase is D326 and D337 in?
D326 and D337 is in Phase 1.
Related
- Manufacturer: Chong Kun Dang Pharmaceutical — full pipeline
- Also known as: CKD-386 Reference2
- Compare: D326 and D337 vs similar drugs
- Pricing: D326 and D337 cost, discount & access